Yehuda Eliya - 12 May 2022 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role
Director
Signature
/s/ Yehuda Eliya
Issuer symbol
RAPH
Transactions as of
12 May 2022
Transactions value $
$0
Form type
4
Filing time
12 Mar 2025, 19:51:29 UTC
Previous filing
19 Jan 2022
Next filing
13 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPH Warrant to purchase Common Stock Award $0 +200K $0.00 200K 10 Mar 2025 Common Stock 200K $1.00 Direct F1
transaction RAPH Warrant to purchase Common Stock Expiration of short derivative position $0 -202K -100% $0.00 0 12 May 2022 Common Stock 202K $1.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 200,000 warrants to purchase Common Stock of the issuer were received as compensation for the reporting person's service as a director of the issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 10, 2025. The Warrants are exercisable immediately and will expire on March 10, 2026.
F2 202,000 warrants to purchase Common Stock of the issuer expired on May 12, 2024, and are no longer beneficially owned by the reporting person.